JSM 2005 - Toronto

JSM Activity #512

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.



The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Add To My Program
512 Applied Session Theme Session Thu, 8/11/05, 10:30 AM - 12:20 PM MCC-208 C
Biopharmaceutical Applications and Related Topics in Survival - Contributed - Papers
Biometrics Section, Biopharmaceutical Section, WNAR
Chair(s): Susan Willavize, Pfizer, Inc.
     10:35 AM   Additive Risk Model for Studies with Two-stage Data — Gang Li, University of California, Los Angeles; Yu Zhao, University of California, Los Angeles
     10:50 AM   Survival Analysis in Two-stage Randomization with Sequential Consent Information — Abdus Wahed, University of Pittsburgh
     11:05 AM   Estimation of Survival Distributions in Two-stage Randomization Designs with Censored Survival Data — Xiang Guo, North Carolina State University; Anastasios A. Tsiatis, North Carolina State University
     11:20 AM   Estimating the Cumulative Incidence of a Competing Risk when Data Are Subject to Left-truncation — Bingshu E. Chen, National Institutes of Health; Joan Kramer, National Institutes of Health; Mark H. Greene, National Institutes of Health; Philip S. Rosenberg, National Cancer Institute
     11:35 AM   A Class of Supreme Version Tests for Comparing Cumulative Incidence — Juhui Jiao, Roche
     11:50 AM   Sample Size Calculation for Composite Endpoints in Survival Trials — Hongyan Zhang, Merck & Co., Inc.
     12:05 PM   Floor Discussion
 

JSM 2005 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2005